openPR Logo
Press release

The Market For Gene Therapy Is Likely To Be Valued At US$ 10.1 Billion by 2032

11-09-2022 05:25 PM CET | Health & Medicine

Press release from: Fact.MR

Gene Therapy Market

Gene Therapy Market

Over the last few years, the world has seen a significant increase in focus on health care, which has resulted in a massive increase in research and development activities. The rising prevalence of rare diseases has also increased the demand for novel treatments, which has driven gene therapy market potential in the past. A CAGR of 18.7% was recorded for the market from 2015 to 2021.

The increasing use of gene modification in a variety of treatments, as well as the increasing use of genome editing in biotechnology applications, are also expected to guide the gene therapy market in the coming years. The global gene therapy industry is expected to be hampered by high gene therapy costs and a lack of standardization. From 2022 to 2032, demand for gene therapies is expected to grow at an astronomical CAGR of 18.5%.

๐—–๐—น๐—ถ๐—ฐ๐—ธ ๐—›๐—ฒ๐—ฟ๐—ฒ ๐—ง๐—ผ ๐—ด๐—ฒ๐˜ ๐—ฎ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ (๐—œ๐—ป๐—ฐ๐—น๐˜‚๐—ฑ๐—ถ๐—ป๐—ด ๐—™๐˜‚๐—น๐—น ๐—ง๐—ข๐—–, ๐—ง๐—ฎ๐—ฏ๐—น๐—ฒ & ๐—™๐—ถ๐—ด๐˜‚๐—ฟ๐—ฒ๐˜€): ๐—ต๐˜๐˜๐—ฝ๐˜€://๐˜„๐˜„๐˜„.๐—ณ๐—ฎ๐—ฐ๐˜๐—บ๐—ฟ.๐—ฐ๐—ผ๐—บ/๐—ฐ๐—ผ๐—ป๐—ป๐—ฒ๐—ฐ๐˜๐˜‚๐˜€/๐˜€๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ?๐—ณ๐—น๐—ฎ๐—ด=๐—ฆ&๐—ฟ๐—ฒ๐—ฝ_๐—ถ๐—ฑ=๐Ÿฐ๐Ÿฒ๐Ÿฐ๐Ÿด

๐—ฃ๐—ฟ๐—ผ๐—บ๐—ถ๐—ป๐—ฒ๐—ป๐˜ ๐—š๐—ฒ๐—ป๐—ฒ ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—š๐—ฟ๐—ผ๐˜„๐˜๐—ต ๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜€

Research and development (R&D) activities are also expected to have a significant impact on the market. Several companies are aiming to build a gene therapy platform with a strategy centered on establishing a transformational portfolio through in-house capabilities and enhancing those capabilities through strategic collaborations, R&D expansion, and potential licensing, merger, and acquisition activities.
For example, the Cystic Fibrosis Foundation announced an investment in SalioGen Therapeutics in January 2022 to support the company's preclinical research into novel gene therapy for cystic fibrosis. SalioGen's Gene Coding approach is intended to activate, deactivate, or modify the function of any gene in the genome.

๐—ž๐—ฒ๐˜† ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐—ถ๐—ป ๐—š๐—ฒ๐—ป๐—ฒ ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต

By Product :
โ€ข Yescarta-based Gene Therapy
โ€ข Kymriah-based Gene Therapy
โ€ข Luxturna-based Gene Therapy
โ€ข Strimvelis-based Gene Therapy
โ€ข Gendicine
โ€ข Others

By Application :
โ€ข Ophthalmology
โ€ข Oncology
โ€ข Adenosine Deaminase/Deficient Severe Combined Immunodeficiency (ADA-SCID)

By Region :
โ€ข North America
โ€ข Latin America
โ€ข Europe
โ€ข East Asia
โ€ข South Asia
โ€ข MEA

๐—ข๐—ป๐—ฐ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฐ๐˜๐—ฒ๐—ฑ ๐˜๐—ผ ๐—”๐—ฐ๐—ฐ๐—ผ๐˜‚๐—ป๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฎ ๐—ฆ๐—ถ๐˜‡๐—ฎ๐—ฏ๐—น๐—ฒ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฆ๐—ต๐—ฎ๐—ฟ๐—ฒ ๐—ฏ๐˜† ๐—”๐—ฝ๐—ฝ๐—น๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป

The cancer segment is expected to account for a sizable portion of the market. The increasing burden of cancer disorder, the growing emphasis on research to develop an effective cancer treatment, and rising cancer research investments are all factors driving the segment growth.
According to Globocan 2020, an estimated 19,292,789 new cancer cases and 9,958,133 cancer deaths were reported worldwide in 2020. Various gene therapy strategies are currently being used in the treatment of cancer. These include anti-angiogenic gene therapy, pro-drug activating suicide gene therapy, immune modulation based on gene therapy, oncolytic virotherapy, gene defect correction/compensation, antisense, genetic manipulation of apoptotic and tumor invasion pathways, and RNAi strategies. These therapies have targeted cancer types such as lung, brain, breast, pancreatic, liver, colorectal, prostate, bladder, head and neck, skin, renal and ovarian cancer.

๐—š๐—ฒ๐˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ป ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ ๐—–๐—ผ๐˜‚๐—ป๐˜๐—ฟ๐˜† - ๐—ต๐˜๐˜๐—ฝ๐˜€://๐˜„๐˜„๐˜„.๐—ณ๐—ฎ๐—ฐ๐˜๐—บ๐—ฟ.๐—ฐ๐—ผ๐—บ/๐—ฐ๐—ผ๐—ป๐—ป๐—ฒ๐—ฐ๐˜๐˜‚๐˜€/๐˜€๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ?๐—ณ๐—น๐—ฎ๐—ด=๐—ฅ๐—–&๐—ฟ๐—ฒ๐—ฝ_๐—ถ๐—ฑ=๐Ÿฐ๐Ÿฒ๐Ÿฐ๐Ÿด

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ

The global gene therapy market is fiercely competitive, with only a few major players. Companies like Amgen Inc., Bluebird Bio, Gilead Sciences, Inc., Novartis AG, Orchard Therapeutics, Sibiono GeneTech Co. Ltd., Spark Therapeutics (Roche AG), and UniQure N.V., have a sizable market share in the Gene Therapy market. To secure a position in the global market, various strategic alliances such as collaborations, acquisitions, and the launch of advanced products have been formed.
โ€ข In October 2021, the National Institutes of Health, the United States Food and Drug Administration, ten pharmaceutical companies, and five non-profit organizations announced a collaboration to accelerate the development of gene therapies for the 30 million Americans who suffer from a rare disease. Such initiatives are expected to boost demand for gene therapy.
โ€ข BioMarin Pharmaceutical Inc. reported updates on its investigational gene therapy programs in clinical development in February 2022. The Food and Drug Administration (FDA) issued additional requests to the Company for information needed to resolve the clinical hold of the PHEARLESS Phase 1/2 study of BMN 307 issued in September 2021.
โ€ข Novartis acquired Gyroscope Therapeutics in December 2021, adding a one-time gene therapy that could transform care for geographic atrophy, a leading cause of blindness.
โ€ข Abecma (idecabtagene vicleucel), a cell-based gene therapy, was approved by the US Food and Drug Administration in March 2021 to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy. Abecma is the first FDA-approved cell-based gene therapy for the treatment of multiple myeloma.

๐—ž๐—ฒ๐˜† ๐—–๐—ต๐—ฎ๐—น๐—น๐—ฒ๐—ป๐—ด๐—ฒ๐˜€ ๐—ฃ๐—ฟ๐—ฒ๐˜ƒ๐—ฎ๐—น๐—ฒ๐—ป๐˜ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—š๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—š๐—ฒ๐—ป๐—ฒ ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜

Gene therapies are expensive medical procedures that necessitate significant capital investment on the part of both the provider and the patient, which limits the global gene therapy market's growth.
Gene modifications necessitate precision equipment, which significantly raises the cost of cell and gene therapy and limits the global adoption of these therapies. Due to high costs and low adoption, viral vector gene therapies are expected to grow at the slowest rate.

๐—™๐—ผ๐—ฟ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€:

https://www.prnewswire.com/news-releases/six-out-of-every-ten-ariel-work-platform-sold-worldwide-is-reported-from-asia-pacific-301411893.html

https://www.prnewswire.com/news-releases/as-investment-in-road-infrastructure-grows-recycled-asphalt-market-will-be-positioned-to-surpass-us-10-7-bn-by-2031--301412860.html

https://www.prnewswire.com/news-releases/aviation-lubricants-market-to-grow-by-1-6x-as-air-passenger-traffic-burgeons-post-pandemic-301414179.html

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

About Us:
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Market For Gene Therapy Is Likely To Be Valued At US$ 10.1 Billion by 2032 here

News-ID: 2800409 • Views: โ€ฆ

More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA โ€ฆ
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % betweenโ€ฆ
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; โ€ฆ
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand forโ€ฆ
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva โ€ฆ
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Keyโ€ฆ
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico โ€ฆ
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rateโ€ฆ

All 5 Releases


More Releases for Gene

DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene โ€ฆ
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034" The DNA and Gene Cloning Services Market Size is valuedโ€ฆ
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther โ€ฆ
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period? The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88โ€ฆ
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy โ€ฆ
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases byโ€ฆ
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma โ€ฆ
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells withโ€ฆ
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In โ€ฆ
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks. The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,โ€ฆ
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische โ€ฆ
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goalโ€ฆ